Abstract

Acquisition of a healthy lifestyle through diet has driven the food manufacturing industry to produce new food products with high nutritional quality. In this sense, consumption of bioactive compounds has been associated with a decreased risk of suffering chronic diseases. Nonetheless, due to their low solubility in aqueous matrices, high instability in food products during processing and preparation as well as poor bioavailability, the use of such compounds is sometimes limited. Recent advancements in encapsulation and protection of bioactive compounds has opened new possibilities for the development of novel food products. In this direction, the present review is attempting to describe encapsulation achievements, with special attention to nanostructured lipid-based delivery systems, i.e., nanoemulsions, multi-layer emulsions and liposomes. Functionality of bioactive compounds is directly associated with their bioavailability, which in turn is governed by several complex processes, including the passage through the gastrointestinal tract and transport to epithelial cells. Therefore, an overview of recent research on the properties of these nanostructured lipid-based delivery systems with a strong impact on the functionality of bioactive compounds will be also provided. Nanostructured lipid-based delivery systems might be used as a potential option to enhance the solubility, stability, absorption and, ultimately, functionality of bioactive compounds. Several studies have been performed in this line, modifying the composition of the nanostructures, such as the lipid-type or surfactants. Overall, influencing factors and strategies to improve the efficacy of encapsulated bioactive compounds within nanostructures have been successfully identified. This knowledge can be used to design effective targeted nanostructured lipid-based delivery systems for bioactive compounds. However, there is still a lack of information on food interactions, toxicity and long-term consumption of such nanostructures.

Highlights

  • The World Health Organization (WHO) reported that by 2020, chronic diseases will be responsible for nearly three-quarters of all deaths worldwide, including ischaemic heart disease, deaths due to stroke and diabetes [1]

  • Mun and co-authors reported that the particle size of a bi-layer emulsion (Tween 20-chitosan) was affected by the chitosan’s degree of deacetylation (DDA), presenting lower particle sizes than those emulsions containing the chitosan with the lowest DDA [41]

  • Many lines of evidence have demonstrated that the use of differentiated monolayers (Caco-2 and Caco-2/HT29-MTX cocultures) with tight junctions best represent the morpho-functional features of the intestinal barrier to model the absorption of lipophilic bioactive compound in epithelial cells [107]

Read more

Summary

Introduction

The World Health Organization (WHO) reported that by 2020, chronic diseases will be responsible for nearly three-quarters of all deaths worldwide, including ischaemic heart disease, deaths due to stroke and diabetes [1]. In an attempt to satisfy the consumer’s requests, the food industry is trying to use and incorporate these bioactive compounds within foodstuffs [4] They present several limitations, including low water solubility, stability and bioavailability, which can compromise successful incorporation and functionality. Different types of carrier systems have been developed, including nanoemulsions [7], double emulsions [8], multi-layer emulsions [9], liposomes [10] and solid lipid nanoparticles [11], among others These systems allow the solubilisation, encapsulation and protection of bioactive compounds, and improve their stability under certain environments such as heat, extreme pH and gastrointestinal fluids [12]. This review will be focused on discussing the use of nanostructured lipid-based delivery systems for enhancing the functionality of lipophilic bioactive compounds

Lipophilic Bioactive Compounds
Nanostructured
Nanoemulsions
Multi-Layer Emulsions
Liposomes
Enhancing Functionality of Nanostructured Lipid-Based Delivery Systems
Enhancing Stability of Lipophilic Bioactive Compounds
Main Findings
Enhancing Absorption of Lipophilic Bioactive Compounds in Epithelial Cells
Application of Nanostructured Lipid-Based Delivery Systems
Concluding Remarks and Future Prospects
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.